Highlights 2005-2006
CSL Bioplasma Products
Annual Report Contents > Business Features > CSL Bioplasma Feature > CSL Bioplasma Products
banner


Major plasma products manufactured by CSL Bioplasma


Coagulation Therapies

Coagulation therapies are used to treat bleeding disorders such as haemophilia and Von Willebrand disease.
Biostate®
MonoFix® -VF
Prothrombinex™ - HT

Immunoglobulins

Immunoglobulins are used to modify function of the immune system.

Intragam® P
Normal Immunoglobulin
Rh(D) Immunoglobulin
CMV Immunoglobulin
Hepatitis B Immunoglobulin
Zoster Immunoglobulin
Tetanus Immunoglobulin

Critical Care Products

Critical care products are used for plasma volume expansion and for replacement of albumin.

Albumex®
Thrombotrol®

Diagnostic Products

Diagnostic products are used to determine compatibility of donor-recipient blood in transfusion settings.

ABO Monoclonal Reagents
Reagent Red Blood Cells

Toll Fractionation Services

CSL Bioplasma performs plasma fractionation for Australia’s National Blood Authority, a role pivotal to Australia’s policy of self-sufficiency. CSL Bioplasma is also the national fractionator of New Zealand, Hong Kong, Malaysia and Singapore.

CSL Behring Plasma Therapeutics

CSL Bioplasma markets CSL Behring’s commercial products in Asia through CSL Behring Asia.

Back | Next